Angiotensin 2 Receptor Blocker
Cross-indication landscape: approved drugs, active Phase 3, sponsors, and upcoming readouts.
17 FDA-approved Angiotensin 2 Receptor Blocker drugs, including AVAPRO, with 33 active Phase 3 trials across 8 indications from 7 active sponsors. Explore approved drugs, the cross-indication pipeline, sponsors, and the Phase 3 readout calendar below.
Approved Angiotensin 2 Receptor Blocker Drugs
17 totalAngiotensin 2 Receptor Blocker Indications in Trials
Active industry trialsActive industry trials by indication. Click to see the full pipeline.
Top Angiotensin 2 Receptor Blocker Sponsors
Industry trials, any indicationCompanies with active industry trials in this mechanism.
Methodology
Approved drugs sourced from FDA `pharmClassEpc` (Established Pharmacologic Class) labeling. Active industry trials matched by intervention name (brand or generic) — same coverage approach as our target pages, with the same limitation: pre-approval candidates using development codes won't match until they're approved.
"Active" = RECRUITING / ACTIVE_NOT_RECRUITING / NOT_YET_RECRUITING. Sponsor counts include any company running at least one active industry trial.